Results 1 to 10 of about 1,018,275 (289)

Coxiella burnetii vascular graft infection [PDF]

open access: yesBMC Infectious Diseases, 2005
Background Coxiella burnetii, the causative agent of Q fever, may cause culture-negative vascular graft infections. Very few cases of C. burnetii infection of a vascular graft have been reported. All were diagnosed by serology.
Von Segesser Ludwig   +6 more
doaj   +3 more sources

Inhibition of vein graft remodeling and neo-intimal formation using a cobalt chrome external support

open access: yesArchives of Clinical and Experimental Surgery, 2018
Objective: Despite significant advances in the understanding of vein graft remodeling during the post-implantation, vein graft disease is still a major limitation of surgical revascularization. The study objective was to evaluate the performance of a new
Samy Nitecki   +3 more
doaj   +1 more source

Evaluation of small-diameter silk vascular grafts implanted in dogsCentral MessagePerspective

open access: yesJTCVS Open, 2021
Objectives: Vascular replacement is one treatment for cardiovascular disease. However, in blood vessels with a diameter less than 6 mm, the existing artificial vascular grafts may be occluded by thrombus formation or intimal hyperplasia.
Takashi Tanaka, DVM, PhD   +5 more
doaj   +1 more source

Streptococcus anginosus and Coxiella burnetii vascular graft co-infection

open access: yesIDCases, 2020
Vascular graft infections are rare complications, usually associated with a monomicrobial pyogenic culture. We report a case of vascular graft co-infection with Streptococcus anginosus and Coxiella burnetii, complicated by an aorto-duodenal fistula ...
Sybille Dvorak, Alain Bizzini
doaj   +1 more source

Silver-coated dacron prosthesis in the treatment of infection in arterial surgery: Case reports [PDF]

open access: yesSrpski Arhiv za Celokupno Lekarstvo, 2008
INTRODUCTION Although the incidence is low, infection of prosthetic vascular graft bears a high incidence of serious complications including 25-75% mortality rate and 40-75% limb loss.
Nenezić Dragoslav   +7 more
doaj   +1 more source

Development of In Vitro Bioengineered Vascular Grafts for Microsurgery and Vascular Surgery Applications

open access: yesPlastic and Reconstructive Surgery, Global Open, 2019
Introduction:. The use of vascular grafts is continuing to rise due to the increasing prevalence of coronary artery bypass grafting and microvascular flap-based tissue reconstructions.
Gurtej Singh, PhD   +9 more
doaj   +1 more source

Anatomical limits in living donor liver transplantation

open access: yesKorean Journal of Transplantation, 2022
We review the anatomical limits of living donor liver transplantation. Graft size is the fundamental challenge in partial liver transplantation. Insufficient graft size leads to small-for-size syndrome, graft failure, and graft loss.
Kin Pan Au, Kenneth Siu Ho Chok
doaj   +1 more source

Acellular Human Placenta Small-Diameter Vessels as a Favorable Source of Super-Microsurgical Vascular Replacements: A Proof of Concept

open access: yesBioengineering, 2023
In this study, we aimed to evaluate the human placenta as a source of blood vessels that can be harvested for vascular graft fabrication in the submillimeter range. Our approach included graft modification to prevent thrombotic events.
Florian Falkner   +13 more
doaj   +1 more source

Surgical and antimicrobial treatment of prosthetic vascular graft infections at different surgical sites: a retrospective study of treatment outcomes. [PDF]

open access: yesPLoS ONE, 2014
Little is known about optimal management of prosthetic vascular graft infections, which are a rare but serious complication associated with graft implants.
Stefan Erb   +6 more
doaj   +1 more source

Over-the-balloon placement of the Gore Hybrid Vascular Graft in challenging clinical conditions

open access: yesJournal of Vascular Surgery Cases and Innovative Techniques, 2016
This report describes a useful technique for deployment of the Gore Hybrid Vascular Graft (W. L. Gore and Associates, Flagstaff, Ariz) in difficult clinical situations that create challenges in obtaining vascular control before introducing the nitinol ...
Scott S. Berman, MD, MHA, FACS   +1 more
doaj   +1 more source

Home - About - Disclaimer - Privacy